JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seino, A.
Right arrow Articles by Ohizumi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seino, A.
Right arrow Articles by Ohizumi, Y.

9-methyl-7-bromoeudistomin D, a powerful radio-labelable Ca++ releaser having caffeine-like properties, acts on Ca(++)-induced Ca++ release channels of sarcoplasmic reticulum

A Seino, M Kobayashi, J Kobayashi, YI Fang, M Ishibashi, H Nakamura, K Momose and Y Ohizumi

Mitsubishi Kasel Institute of Life Sciences, Tokyo, Japan.

9-Methyl-7-bromoeudistomin D (MBED), a derivative of eudistomin D isolated from a marine tunicate, induced Ca++ release from the heavy fraction of fragmented sarcoplasmic reticulum (HSR) in the same way as that of caffeine, followed by spontaneous Ca++ reuptake in the Ca++ electrode experiment. The rate of 45Ca++ efflux from HSR vesicles was accelerated markedly by MBED or caffeine in a concentration-dependent manner. The 50% effective concentrations of MBED and caffeine were approximately 1 microM and 1 mM, respectively, indicating that MBED is 1000 times more potent than caffeine in HSR. Procaine, ruthenium red or Mg++ caused concentration-dependent inhibition of MBED-triggered Ca++ release from HSR. The bell-shaped profile of Ca++ dependence for MBED is very similar to that of caffeine. The caffeine-produced maximum response of 45Ca++ efflux was increased further by adenosine-5'-(beta, gamma-methyl-ene)triphosphate, whereas that was not changed by MBED. MBED also caused Ca++ release from sarcoplasmic reticulum (SR) of chemically skinned fibers. These stimulatory effects of MBED on the Ca++ release from skeletal muscle SR were almost indistinguishable from those of caffeine except the difference in potencies. The [3H]ryanodine binding to junctional terminal cisternae membranes was not inhibited by MBED or caffeine. MBED did not cause Ca++ release from the light fraction of fragmented SR and turbidity change of mitochondrial suspension. These observations suggest a most likely idea that MBED binds to the caffeine-binding site in the Ca channel protein and thus produces the potentiation of Ca(++)-induced Ca++ release from SR.(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 256, Issue 3, pp. 861-867, 03/01/1991
Copyright © 1991 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
R. Laporte, A. Hui, and I. Laher
Pharmacological Modulation of Sarcoplasmic Reticulum Function in Smooth Muscle
Pharmacol. Rev., December 1, 2004; 56(4): 439 - 513.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. M. Thomas, G. C. Churchill, S. Patel, and A. Galione
Distinct Pharmacology of 2-Hydroxycarbazole-Induced Ca2+ Release in the Sea Urchin Egg
J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 644 - 650.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. Hirata, N. Nakahata, and Y. Ohizumi
Identification of a 97-kDa Mastoparan-Binding Protein Involving in Ca2+ Release from Skeletal Muscle Sarcoplasmic Reticulum
Mol. Pharmacol., June 1, 2000; 57(6): 1235 - 1242.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Suzuki, K. Matsunaga, H. Shin, J. Tabudrav, Y. Shizuri, and Y. Ohizumi
Bisprasin, a Novel Ca2+ Releaser with Caffeine-Like Properties from a Marine Sponge, Dysidea spp., Acts on Ca2+-Induced Ca2+ Release Channels of Skeletal Muscle Sarcoplasmic Reticulum
J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 725 - 730.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Ito, Y. Hirata, H. Nakamura, and Y. Ohizumi
Xestoquinone, Isolated from Sea Sponge, Causes Ca2+ Release through Sulfhydryl Modification from Skeletal Muscle Sarcoplasmic Reticulum
J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 976 - 981.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Ohizumi, K. Matsunaga, K. Nakatani, and J.'i. Kobayashi
Potent Stimulation of Myofilament Force and ATPase Activity of Skeletal Muscle by Eudistomin M, a Novel Ca++-Sensitizing Agent from a Caribbean Tunicate
J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 695 - 699.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
R. Zucchi and S. Ronca-Testoni
The Sarcoplasmic Reticulum Ca2+ Channel/Ryanodine Receptor: Modulation by Endogenous Effectors, Drugs and Disease States
Pharmacol. Rev., March 1, 1997; 49(1): 1 - 52.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. El-Hayek, A. J. Lokuta, C. Arévalo, and H. H. Valdivia
Peptide Probe of Ryanodine Receptor Function
J. Biol. Chem., December 1, 1995; 270(48): 28696 - 28704.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1991 by the American Society for Pharmacology and Experimental Therapeutics.